Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, it is hereby informed that the Officials of Supriya Lifescience Limited ('Company') had interacted with institutional investors/analysts on March 16, 2022 via video conference. This is to further inform that the copy of the Investor Presentation which was referred during the meeting has been already uploaded on the website of the Company www.supriyalifescience.com and is also available on the Stock Exchanges for the public at large. No unpublished price sensitive information (UPSI) was discussed during the interactions. Request you to kindly take the same on record.
16-03-2022
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, it is hereby informed that the Officials of Supriya Lifescience Limited ('Company') had interacted with institutional investors/analysts on March 14, 2022 via video conference. This is to further inform that the copy of the Investor Presentation which was referred during the meeting has been already uploaded on the website of the Company www.supriyalifescience.com and is also available on the Stock Exchanges for the public at large. No unpublished price sensitive information (UPSI) was discussed during the interactions. Request you to kindly take the same on record.
14-03-2022
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will be interacting with Analysts/Investors on March 11, 2022 via video conference. This is to further inform that the copy of the Investor Presentation which was referred during the meeting has been already uploaded on the website of the Company www.supriyalifescience.com and is also available on the Stock Exchanges for the public at large. No unpublished price sensitive information (UPSI) was discussed during the interactions. Request you to kindly take the same on record.
10-03-2022
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we would like to inform you that the officials of the Company will be organizing plant visit for Analysts at Lote, Maharashtra on March 09, 2022. This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the website of the Company www.supriyalifescience.com for your information and for the information of your members and the public at large. Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund. Request you to kindly take the same on record.
08-03-2022
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, it is hereby informed that the Officials of Supriya Lifescience Limited ('Company') had interacted with institutional investors/analysts on March 7, 2022 via video conference. This is to further inform that the copy of the Investor Presentation which was referred during the meeting has been already uploaded on the website of the Company www.supriyalifescience.com and is also available on the Stock Exchanges for the public at large. No unpublished price sensitive information (UPSI) was discussed during the interactions. Request you to kindly take the same on record.
07-03-2022
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, it is hereby informed that the Officials of Supriya Lifescience Limited ('Company') had interacted with institutional investor/analyst on March 4, 2022 via video conference. This is to further inform that the copy of the Investor Presentation which was referred during the meeting has been already uploaded on the website of the Company www.supriyalifescience.com and is also available on the Stock Exchanges for the public at large. No unpublished price sensitive information (UPSI) was discussed during the interactions. Request you to kindly take the same on record.
04-03-2022
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will be interacting with Analysts/Investors on March 2, 2022 and March 3, 2022 via video conference. This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company's website www.supriyalifescience.com for your information and for the information of your members and the public at large. This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund. Request you to kindly take the same on record.
01-03-2022
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will be interacting with Analysts/Investors on March 1, 2022 via video conference. This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company's website www.supriyalifescience.com for your information and for the information of your members and the public at large. This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund. Request you to kindly take the same on record.
28-02-2022
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will be interacting with Analysts/Investors on February 25, 2022 via video conference. This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company's website www.supriyalifescience.com for your information and for the information of your members and the public at large. This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund. Request you to kindly take the same on record.
24-02-2022
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, it is hereby informed that the Officials of Supriya Lifescience Limited ('Company') had interacted with institutional investor/analyst on 15th February 2022 via video conference. This is to further inform that the copy of the Investor Presentation which was referred during the meeting has been already uploaded on the website of the Company www.supriyalifescience.com and is also available on the Stock Exchanges for the public at large. No unpublished price sensitive information (UPSI) was discussed during the interactions. Request you to kindly take the same on record.
15-02-2022
Next Page
Close

Let's Open Free Demat Account